prednisolone has been researched along with Pityriasis Rosea in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Pityriasis Rosea: A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of short-course low-dose oral prednisolone in symptomatic pityriasis rosea (PR) of onset <5 days and compare it with placebo." | 9.27 | Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea. ( Gupta, A; Kumar, A; Priya, A; Sonthalia, S; Srivastava, S; Yadav, P; Zawar, V, 2018) |
| "To evaluate the efficacy and safety of short-course low-dose oral prednisolone in symptomatic pityriasis rosea (PR) of onset <5 days and compare it with placebo." | 5.27 | Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea. ( Gupta, A; Kumar, A; Priya, A; Sonthalia, S; Srivastava, S; Yadav, P; Zawar, V, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonthalia, S | 1 |
| Kumar, A | 1 |
| Zawar, V | 1 |
| Priya, A | 1 |
| Yadav, P | 1 |
| Srivastava, S | 1 |
| Gupta, A | 1 |
1 trial available for prednisolone and Pityriasis Rosea
| Article | Year |
|---|---|
Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Double-Blind Method; Drug Administration Sched | 2018 |